A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management

• URL: http://arxiv.org/abs/2409.01903v1
• Date: Tue, 3 Sep 2024 13:50:59 GMT
• Title: A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
• Authors: Abdelmalek Mouazer, Sophie Dubois, Romain Léguillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte Séroussi, Julien Grosjean, Romain Lelong, Catherine Letord, Stéfan Darmoni, Karima Sedki, Pierre Meneton, Rosy Tsopra, Hector Falcoff, Jean-Baptiste Lamy,
• Abstract summary: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial.
• Score: 3.8243906257653504
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.

Related papers

• Leave No Patient Behind: Enhancing Medication Recommendation for Rare Disease Patients [47.68396964741116]
  We propose a novel model called Robust and Accurate REcommendations for Medication (RAREMed) to enhance accuracy for rare diseases. It employs a transformer encoder with a unified input sequence approach to capture complex relationships among disease and procedure codes. It provides accurate drug sets for both rare and common disease patients, thereby mitigating unfairness in medication recommendation systems.
  arXiv  Detail & Related papers  (2024-03-26T14:36:22Z)
• ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management [3.843569766201585]
  The aim of ABiMed is to design an innovative clinical decision support system for medication reviews and polypharmacy management. ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics.
  arXiv  Detail & Related papers  (2023-12-13T11:06:45Z)
• Decision Support System for Chronic Diseases Based on Drug-Drug Interactions [67.9840225237587]
  This paper presents a Decision Support System, called DSSDDI, based on drug-drug interactions to support doctors prescribing decisions. The DDI module learns safer and more effective drug representations from the drug-drug interactions. The MD module considers the representations of patients and drugs as context, DDI and patients' similarity as treatment, and medication use as outcome.
  arXiv  Detail & Related papers  (2023-03-04T12:44:38Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• Conditional Generation Net for Medication Recommendation [73.09366442098339]
  Medication recommendation targets to provide a proper set of medicines according to patients' diagnoses, which is a critical task in clinics. We propose Conditional Generation Net (COGNet) which introduces a novel copy-or-predict mechanism to generate the set of medicines. We validate the proposed model on the public MIMIC data set, and the experimental results show that the proposed model can outperform state-of-the-art approaches.
  arXiv  Detail & Related papers  (2022-02-14T10:16:41Z)
• RecoMed: A Knowledge-Aware Recommender System for Hypertension Medications [1.2633386045916444]
  This paper aims to develop a medicine recommender system called RecoMed to aid the physician in the prescription process of hypertension. A list of recommended medicines is provided as the system's output, and physicians can choose one or more of the medicines based on the patient's clinical symptoms.
  arXiv  Detail & Related papers  (2022-01-09T08:01:41Z)
• Semi-Supervised Variational Reasoning for Medical Dialogue Generation [70.838542865384]
  Two key characteristics are relevant for medical dialogue generation: patient states and physician actions. We propose an end-to-end variational reasoning approach to medical dialogue generation. A physician policy network composed of an action-classifier and two reasoning detectors is proposed for augmented reasoning ability.
  arXiv  Detail & Related papers  (2021-05-13T04:14:35Z)
• Drug Recommendation System based on Sentiment Analysis of Drug Reviews using Machine Learning [0.0]
  We build a medicine recommendation system that uses patient reviews to predict the sentiment using various vectorization processes like Bow, TFIDF, Word2Vec, and Manual Feature Analysis. The results show that LinearSVC using TFIDF vectorization outperforms all other models with 93% accuracy.
  arXiv  Detail & Related papers  (2021-03-24T10:11:18Z)
• Assessment of Amazon Comprehend Medical: Medication Information Extraction [0.3161954199291541]
  Amazon Comprehend Medical (ACM) is a deep learning based system that automatically extracts clinical concepts from clinical text notes. ACM was evaluated using the official test sets from the 2009 i2b2 Medication Extraction Challenge and 2018 n2c2 Track 2: Adverse Drug Events and Medication Extraction in EHRs. Overall, ACM achieved F-scores of 0.768 and 0.828.
  arXiv  Detail & Related papers  (2020-02-02T20:08:34Z)
• Contextual Constrained Learning for Dose-Finding Clinical Trials [102.8283665750281]
  C3T-Budget is a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. It recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group.
  arXiv  Detail & Related papers  (2020-01-08T11:46:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.